U.S. Markets close in 2 hrs 35 mins
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    110.30
    +1.87 (+1.72%)
     
  • Gold

    1,807.40
    +5.90 (+0.33%)
     
  • Silver

    19.86
    +0.19 (+0.98%)
     
  • EUR/USD

    1.0428
    +0.0001 (+0.0104%)
     
  • 10-Yr Bond

    2.8890
    0.0000 (0.00%)
     
  • Vix

    26.70
    -2.01 (-7.00%)
     
  • GBP/USD

    1.2109
    +0.0006 (+0.0484%)
     
  • USD/JPY

    135.6670
    +0.4920 (+0.3640%)
     
  • BTC-USD

    19,669.16
    -150.98 (-0.76%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • FTSE 100

    7,232.65
    +64.00 (+0.89%)
     
  • Nikkei 225

    26,153.81
    +218.19 (+0.84%)
     

CVS Health (CVS) Stock Moves -1.75%: What You Should Know

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

In the latest trading session, CVS Health (CVS) closed at $89.85, marking a -1.75% move from the previous day. This change was narrower than the S&P 500's 3.25% loss on the day. At the same time, the Dow lost 2.42%, and the tech-heavy Nasdaq lost 0.49%.

Prior to today's trading, shares of the drugstore chain and pharmacy benefits manager had lost 2.73% over the past month. This has was narrower than the Retail-Wholesale sector's loss of 4.53% and the S&P 500's loss of 5.62% in that time.

CVS Health will be looking to display strength as it nears its next earnings release. In that report, analysts expect CVS Health to post earnings of $2.15 per share. This would mark a year-over-year decline of 11.16%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $76.53 billion, up 5.39% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of $8.33 per share and revenue of $308.34 billion, which would represent changes of -0.83% and +5.56%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for CVS Health. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.13% higher. CVS Health currently has a Zacks Rank of #3 (Hold).

Looking at its valuation, CVS Health is holding a Forward P/E ratio of 10.97. Its industry sports an average Forward P/E of 8.05, so we one might conclude that CVS Health is trading at a premium comparatively.

It is also worth noting that CVS currently has a PEG ratio of 1.44. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Retail - Pharmacies and Drug Stores industry currently had an average PEG ratio of 1.53 as of yesterday's close.

The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 224, which puts it in the bottom 12% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow CVS in the coming trading sessions, be sure to utilize Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research